Nicholas Mallard - Concepedia

Author

Nicholas Mallard

Reckitt Benckiser (Netherlands)

Also Known As

N. J. Mallard, N. MALLARD, N. Mallard, N.J. Mallard, Nicholas Mallard

Publications

633

Citations

H-Index

Concepts

All Affiliations

Reckitt Benckiser (Netherlands)University of Wales Forschungsinstitut für Kinderernährung

About

Nicholas Mallard is an author at Reckitt Benckiser (Netherlands) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	286
2	Natural Sciences	1	1	39
3	Biochemistry	1	1	39
4	Chemical Biology	1	1	39
5	Neuroscience	1	1	74

Nicholas Mallard

Publications

521

Citations

H-Index

Page 1

	Year	Citations
Characterization and autoradiographical localization of non‐adrenoceptor idazoxan binding sites in the rat brain Nicholas Mallard, Alan L. Hudson, David Nutt British Journal of Pharmacology	1992	120
A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition Anne Clarke, Fred Brewer, E S Johnson, Journal of Neural Transmission Medicinal ChemistryNew FormulationPharmaceutical SciencePharmacologyMao-b Inhibition	2003	119
Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens Nicholas Mallard, R. W. Marshall, Andrew Sithers, European Journal of Pharmacology MedicineSynaptic TransmissionPhysiologyNeurotransmitterSelective Inhibitor	1992	74
A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition Anthony Clarke, E S Johnson, Nicholas Mallard, Journal of Neural Transmission Pharmacological StudyNew Low-dose FormulationPharmacologyMao-b InhibitionPharmacological Agent	2003	54
Separation of putative α<sub>1A</sub>‐ and α<sub>1B</sub>‐ adrenoceptor mediated components in the tension response of the rat vas deferens to electrical field stimulation Nicholas Mallard, R. W. Marshall, Andrew Sithers, British Journal of Pharmacology	1992	43
Ethyl‐eicosapentaenoic acid treatment in Huntington's disease: A placebo‐controlled clinical trial Joaquim J. Ferreira, Anne Rosser, David Craufurd, Movement Disorders	2015	40
Identification of ligands selective for central I2-imidazoline binding sites Alan L. Hudson, Christopher B. Chapleo, John W. Lewis, Neurochemistry International Chemical BiologyBiochemistryNatural SciencesMedicineMolecular Complex	1997	39
A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose‐escalation regimen in patients with erectile dysfunction Alexander T. von Keitz, Peter Ströberg, Stan Bukofzer, British Journal of Urology	2002	32

Page 1